The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

The judge agreed with two doctors that the removal of the articles was a "textbook example" of viewpoint discrimination that ...

Brennan Bernardino took over for the next 1 2/3 innings as the Red Sox improved to 2-0 in the three-game series. Garrett ...

Torrent Pharmaceuticals is entering a new chapter as Aman Mehta, next-gen scion of the Mehta family, prepares to take over as ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Boston Scientific has won a national award that recognises the strength and impact of its collaborative projects.

GSK plc GSK announced that it has signed an agreement with Massachusetts-based biopharmaceutical company Boston ...

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...

GSK will acquire the liver disease drug efimosfermin from Boston Pharmaceuticals in a deal worth up to $2 billion, The Wall Street Journal reported May 14. The agreement includes a $1.2 billion ...